Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate. (23rd July 2018)

• Record Type: Journal Article
• Authors: Hecht, Max; Veigure, Rūta; Couchman, Lewis; S Barker, Charlotte I; Standing, Joseph F; Takkis, Kalev; Evard, Hanno; Johnston, Atholl; Herodes, Koit; Leito, Ivo; Kipper, Karin
• Is Part Of: Bioanalysis. Volume 10:Number 15(2018)
• Page Start: 1229
• Page End: 1248
• Publication Date: 2018-07-23
• Subjects: BLQ -- LOD -- LLOQ -- pharmacodynamics -- pharmacokinetic; Drugs -- Analysis -- Periodicals; 615.19005
• DOI: 10.4155/bio-2018-0078
• Languages: English
• ISSNs: 1757-6180

Abstract

Traditionally, bioanalytical laboratories do not report actual concentrations for samples with results below the LOQ (BLQ) in pharmacokinetic studies. BLQ values are outside the method calibration range established during validation and no data are available to support the reliability of these values. However, ignoring BLQ data can contribute to bias and imprecision in model-based pharmacokinetic analyses. From this perspective, routine use of BLQ data would be advantageous. We would like to initiate an interdisciplinary debate on this important topic by summarizing the current concepts and use of BLQ data by regulators, pharmacometricians and bioanalysts. Through introducing the limit of detection and evaluating its variability, BLQ data could be released and utilized appropriately for pharmacokinetic research.